← WeedVoter

The federal hemp deadline: what actually changes on 12 November 2026, and what changes on 11 December

Re-checked 5 October 2026 against the enrolled text of the public laws themselves on govinfo.gov, the official site of the U.S. Government Publishing Office; the opinion of the Supreme Court of Texas as published on txcourts.gov; the roll call record of the Clerk of the U.S. House; and the Texas Department of State Health Services' own program page. This page describes the law. It does not tell anyone how to vote, and it does not predict what any official, agency or court will do next.

The one thing most reports of this get wrong

You will read that Congress delayed the new federal hemp law by a year. The enrolled text does not say that. The effective date was never moved. What Congress did in September 2026 was narrow, for twenty-nine days, which products the new law reaches. The deadline itself still falls on 12 November 2026, nine days after the Texas election.

That distinction is the whole point of this page, so it is worth saying twice: there are two dates, not one postponed date. On 12 November 2026 a narrow slice of the new definition takes hold. On 11 December 2026 the rest of it does.

The words you need first

Each of these is a term of art — a word that means something narrower in law than in ordinary speech.

• Cannabis sativa L. is the botanical name of the single plant species that produces both what is sold as marijuana and what is sold as hemp. The plant is one species; the legal categories are drawn by chemistry, not by botany.
• A cannabinoid is any one of the roughly one hundred chemical compounds the cannabis plant makes. Some are intoxicating, most are not.
• THC stands for tetrahydrocannabinol, the family of cannabinoids that produce the intoxicating effect people associate with marijuana. Delta-9 tetrahydrocannabinol is the most abundant and most familiar member of that family. Delta-8 tetrahydrocannabinol is a close chemical relative. Tetrahydrocannabinolic acid, usually written THCA, is the inactive form the living plant actually produces; it converts into delta-9 when the plant material is heated, as in smoking or baking.
• Hemp is not a kind of plant. It is a legal category: cannabis that falls under a chemical threshold written into federal law. Cannabis above the threshold is marijuana, a federally controlled substance. Cannabis below it is hemp, and hemp is an agricultural commodity. Change the threshold and you move plants and products across the line without touching the plants.
• A public law is a bill that has completed passage through both chambers of Congress and been signed by the President. It is numbered by Congress and sequence — Public Law 119-37 is the thirty-seventh public law of the 119th Congress — and its authoritative text is the enrolled text, the version actually signed. Summaries, press releases and trade-press accounts are not the law.
• An effective date is the day a law's commands begin to operate. It is often not the day the law was signed. A law can be signed in November 2025 and start working in November 2026, and during that gap the old rules remain the only rules.
• An appropriations rider is a substantive policy provision carried inside a government funding bill. Riders are not amendments to the funding; they are separate law that travels with it, which is how a change to the definition of hemp comes to be numbered as section 781 of an agriculture spending division. A rider gets the funding bill's floor vote, not one of its own.
• "Capable of being naturally produced" is the statute's own phrase, and it is the trickiest one. It asks a question about the plant, not about the product. A cannabinoid is capable of being naturally produced if a cannabis plant can make it at all — even in amounts far too small to have any effect. It says nothing about whether the particular jar on the shelf was made by a plant or in a laboratory. The statute handles that separately, in a different clause. Reading these two clauses as one is the single most common way this law is misdescribed, and the twenty-nine-day window turns entirely on keeping them apart.

What the 2025 law says

The provision is section 781 of division B of Public Law 119-37, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, approved 12 November 2025. Division B is the agriculture and Food and Drug Administration spending division, so section 781 is a rider in the sense defined above. It rewrites section 297A of the Agricultural Marketing Act of 1946 — the provision, added by the 2018 farm bill, that created the legal category of hemp by defining it.

It opens:

Effective 365 days after the enactment of this Act, Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) is amended--

— Public Law 119-37, div. B, sec. 781, 139 Stat. 495, 558.

The statute fixes its own start by counting days from enactment rather than naming a date. The Act was approved 12 November 2025; 365 days later is 12 November 2026.

The new definition reads:

(1) Hemp.--

(A) In general.--The term 'hemp' means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent on a dry weight basis.

— same citation, 139 Stat. 558-559. (The enrolled text sets the inserted definition in internal quotation marks, as amendatory text always is; the words are reproduced exactly.)

Two things changed in that sentence. The 2018 definition measured only delta-9 tetrahydrocannabinol. This one measures total tetrahydrocannabinols, and it says in so many words that the count includes tetrahydrocannabinolic acid. Because raw flower carries most of its potency as THCA, flower that passes a delta-9-only test can fail a total-THC test by a wide margin. That arithmetic is the legal foundation of the product sold as "THCA flower."

The definition then lists what the term does not include. These exclusions are where the November and December dates diverge, so they are worth setting out separately.

For intermediate products — the statute's term for a hemp-derived cannabinoid product "not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal," such as a bulk distillate or concentrate — hemp excludes any such product containing:

(I) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant;

(II) cannabinoids that-- (aa) are capable of being naturally produced by a Cannabis sativa L. plant; and (bb) were synthesized or manufactured outside the plant; or

(III) more than 0.3 percent combined total of-- (aa) total tetrahydrocannabinols (including tetrahydrocannabinolic acid); and (bb) any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services)

— sec. 297A(1)(C)(ii) as amended, 139 Stat. 559.

For final products — the thing a consumer buys — the first two exclusions are worded identically, but the third is a quantity per package rather than a percentage:

(III) greater than 0.4 milligrams combined total per container of-- (aa) total tetrahydrocannabinols (including tetrahydrocannabinolic acid); and (bb) any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).

— sec. 297A(1)(C)(iv)(III) as amended, 139 Stat. 559.

The difference between those two subparagraphs is easy to blur and should not be. Intermediate products get a 0.3 percent concentration cap. Final consumer products get a 0.4 milligram cap per container. A single hemp-derived THC gummy or seltzer sold in Texas today is typically labelled at 5, 10, 25 or 50 milligrams. Against a 0.4 milligram ceiling per container, the margin is not close.

"Container" is defined in the law, and defined tightly:

The term 'container' means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge.

— sec. 297A(3)(C) as amended, 139 Stat. 560. A following subparagraph excludes "bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale." So the cap attaches to the individual gummy pouch or can, not to the case it shipped in.

Two further pieces of the same definition are routinely left out of accounts of this law and matter to real businesses:

• Hemp also excludes any intermediate hemp-derived cannabinoid product "which are marketed or sold as a final product or directly to an end consumer for personal or household use" — sec. 297A(1)(C)(iii). Selling bulk material straight to the public is excluded outright, regardless of potency.
• The definition expressly includes "industrial hemp", separately defined to cover plants grown for stalk and fiber, for grain, oil and other non-cannabinoid seed products, for microgreens and edible leaf, for non-commercial research, and for seed to produce those things — sec. 297A(1)(B) and (2). A fiber or grain operation is not the target of any of this.
• A drug approved under section 505(c) or (j) of the Federal Food, Drug, and Cosmetic Act is excluded from the "hemp-derived cannabinoid product" category — sec. 297A(3)(E). Prescription medicines are on a different track.

Finally, section 781 gave the Food and Drug Administration homework:

Within 90 days of the enactment of this act, the Food and Drug Administration, in consultation with other relevant Federal agencies, shall publish--

— four lists: cannabinoids known to the agency to be capable of being naturally produced by the plant; tetrahydrocannabinol-class cannabinoids known to occur naturally in it; other cannabinoids with similar effects; and "additional information and specificity about the term 'container'" (139 Stat. 560-561). Ninety days from 12 November 2025 fell in February 2026. Those lists are what would decide which specific compounds land on which side of the "capable of being naturally produced" line. We could not find them. See "What is not known," below.

What the September 2026 law says

Public Law 119-103, the Continuing Appropriations and Extensions Act, 2027, was approved 2 September 2026. The House adopted it the day before on a motion to suspend the rules and concur in the Senate amendments to H.R. 6500: 370 Yeas, 48 Nays, 14 not voting, Roll Call 286 of 1 September 2026. Members voted on the entire funding package; there was no separate vote on the hemp language, and the Nays came from both parties.

Section 2019 of that law, in Division B, "Authorizing Extensions," is seven lines long. This is its entire text:

SEC. 2019. SECTION 781 EXTENSION.

Until December 11, 2026, the amendments made by section 781 of division B of Public Law 119-37 (7 U.S.C. 1639o note) shall only apply with respect to products described in paragraphs (1)(C)(ii)(I) and (1)(C)(iv)(I) of section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) (as amended by such section 781).

— Public Law 119-103, div. B, sec. 2019, 140 Stat. 1003.

Read it closely. It does not contain a new effective date. It does not use the word delay. It does not amend section 781. It says the amendments "shall only apply with respect to" two named paragraphs until 11 December. The heading the Government Publishing Office prints beside it in the margin is "Applicability" — not "Effective date."

The two paragraphs it names, (1)(C)(ii)(I) and (1)(C)(iv)(I), are quoted in full above. Both say the same seventeen words: "cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant." One is the intermediate-product version, one the final-product version. Nothing else is in the carve-out — not the total-THC test, not the 0.4 milligram cap, not the clause about cannabinoids synthesised outside the plant, not the ban on selling intermediate product to consumers.

What changes on each date, and for whom

Before 12 November 2026. Federal law is the 2018 definition, added by section 10113 of Public Law 115-334, the Agriculture Improvement Act of 2018, which defined hemp as the plant and its parts and derivatives "with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis" (132 Stat. 4908-4909). One cannabinoid, one number. Nothing in either of the two laws described above is operating yet.

From 12 November 2026 through 10 December 2026. The new definition is in force, but by the terms of section 2019 it reaches only one thing: products containing cannabinoids a cannabis plant is not capable of producing at all. The total-tetrahydrocannabinols test, the 0.4 milligram per container cap, and the exclusion of plant-possible cannabinoids made outside the plant are all written and effective but, during these twenty-nine days, apply to nothing.

From 11 December 2026. The limit in section 2019 runs out and the whole of section 781 operates: total THC including THCA at 0.3 percent, 0.4 milligrams combined total per retail container for final products, 0.3 percent for intermediate ones, the exclusion of cannabinoids synthesised or manufactured outside the plant, and the bar on selling intermediate product directly to consumers.

Here is the consequence that reads backwards until you have the definitions straight, and it is the reason this page exists. A compound like delta-8 tetrahydrocannabinol occurs in the plant in trace amounts, so it is "capable of being naturally produced." The delta-8 actually sold is made by chemically converting another cannabinoid in a laboratory, which is caught by the separate "synthesized or manufactured outside the plant" clause — and that clause is not one of the two paragraphs section 2019 leaves in force. On the face of the statute, lab-converted delta-8 keeps its federal hemp status through 10 December 2026, while a cannabinoid no cannabis plant can make at all loses it on 12 November 2026.

The Supreme Court of Texas described the chemistry the same way when it took up the state's own delta-8 case, calling it "a naturally occurring psychoactive compound found in exceedingly trace amounts in the cannabis plant," distinguished from "artificial products containing a high concentration of manufactured delta-8 THC." That is a state court reading state law, not federal law, but the factual premise is the one the federal phrase turns on.

Which specific compounds fall on each side of "capable of being naturally produced" is exactly what the Food and Drug Administration lists were supposed to settle.

What this means for a Texas consumer

Concretely, and separating the two bodies of law:

• Under Texas law, already, since 31 July 2026: consumable hemp products labelled to contain delta-8 tetrahydrocannabinol, or shown to contain more than trace amounts of tetrahydrocannabinols including delta-8, "may be detained and referred to law enforcement," in the state health department's words. The department's page states that the reinstated schedule means "only naturally occurring trace amounts in a hemp plant are exempt from controlled status." Texas consumable hemp products "may contain delta-9 tetrahydrocannabinol at a concentration of not more than 0.3 percent on a dry weight basis" under Health and Safety Code chapter 443. This is state law and it is in effect now, today, before either federal date.
• Under Texas rules, since 2 October 2025: no sale of consumable hemp products to anyone under 21, and a valid government-issued identification is required before purchase. These came in as emergency rules at 25 Texas Administrative Code sections 300.701 and 300.702, following the Governor's executive order of 10 September 2025.
• From 12 November 2026, federally: a product whose active ingredient is a cannabinoid no cannabis plant can produce is outside the federal definition of hemp.
• From 11 December 2026, federally: a final product carrying more than 0.4 milligrams of total tetrahydrocannabinols and similar-effect cannabinoids in its retail container is outside the federal definition of hemp. That threshold is below the labelled dose of essentially every intoxicating hemp product now on a Texas shelf.

Falling outside the definition of hemp is not a prohibition written in these words; it is the removal of the agricultural-commodity status that made these products lawful to sell in the first place. What follows from that removal depends on federal rulemaking, guidance and enforcement decisions that have not been made, and this page does not guess at them.

What this means for a Texas retailer

• Licensing and fees are state matters and have already moved. The state health department states that the consumable hemp product licence fee "has been restored to $10,000 annually per location," plus the state online fee, and retail hemp registration "has been restored to $5,000 annually per location." Those figures and the other requirements sit in 25 Texas Administrative Code chapter 300.
• The age-21 and identification rules are state rules, and apply to the licensee and the registrant, with revocation of the licence or registration named as a consequence of violation.
• Smokable product sits in an unresolved state posture. The health department's own page records that the Supreme Court of Texas in June 2022 upheld the Texas statute prohibiting the "processing or manufacturing of a consumable hemp product for smoking," while "the lower court's injunction remains, which allows the distribution and retail sale of consumable hemp products for smoking." Both halves of that sentence are the state of play.
• The federal dates bite on the product, not the licence. On 12 November 2026 the federal question for a shelf is whether anything on it depends on a cannabinoid the plant cannot make. On 11 December 2026 the federal question becomes the 0.4 milligram per container ceiling and the total-THC test including THCA, which together reach ordinary hemp-derived delta-9 gummies, drinks and the flower sold as THCA flower.
• Inventory bought before a date is not exempted by either law. Neither section 781 nor section 2019 contains a transition rule, a sell-through period, or a grandfather clause for existing stock. We looked; there is none in the enrolled text. What an agency might do about product already in the channel is a rulemaking and enforcement question, not a statutory one, and is unresolved.

What is not known

This section is deliberately separate from everything above, because the statute's words and the machinery that will implement them are different kinds of fact.

• The Food and Drug Administration lists required by section 781 could not be found. We searched the full text of the Federal Register through the Office of the Federal Register's own programming interface for the statutory phrase "capable of being naturally produced" (zero documents) and for section 781 and hemp-derived cannabinoid rulemaking since 12 November 2025 (nothing on point), and read the agency's standing policy page on cannabis and cannabis-derived products, which does not mention section 781, the lists, or Public Law 119-37. The statute does not say the lists must appear in the Federal Register, so this is a failure to find, not a finding that nothing was published. Until they are located, which compounds are "capable of being naturally produced" is unsettled in practice even though the test is settled in text.
• No implementing regulation has been identified for either date, from the Food and Drug Administration, the Department of Agriculture or any other federal agency.
• No federal enforcement posture is known, and we do not forecast one. A product falling outside a definition and a product being seized are different events, and only the first is established by a statute.
• The status of bills to repeal or further change section 781 is not established here. The congressional bill-status service asks automated tools not to read it, so we did not read it. What we can state is narrower and firmer: see the next section.
• How federal and Texas law will interact in practice is not resolved. Both apply. A product can be lawful under one and not the other. Nothing on this page resolves a conflict between them, because no authority has.

How we checked that the deadline never moved

The claim that the 12 November 2026 effective date was never changed is only worth as much as the search behind it, so here is the search.

We retrieved the enrolled text of every public law of the 119th Congress from 119-38 through 119-117 — Public Law 119-117 was approved 25 September 2026 and is the last one published as of this check — from govinfo.gov, and searched each for "1639o," "section 781" and "hemp." Three laws matched, and none of them touches this:

• Public Law 119-44 (approved 1 December 2025) amends "Section 781(j) of the Public Health Service Act (42 U.S.C. 295h(j))" — a different section 781 of a different statute, about a substance use disorder treatment workforce program.
• Public Law 119-74 (approved 23 January 2026) carries a long-standing spending restriction referring to industrial hemp research under the Agricultural Act of 2014. It does not touch section 297A.
• Public Law 119-103 is section 2019, quoted above in full.

So: one subsequent enactment mentions section 781 of Public Law 119-37, and it narrows the scope of the amendments for twenty-nine days without altering when they take effect. The established reading holds. The trade-press description of a blanket one-year delay is not what the enrolled text says.

Which rules are federal and which are Texas

Both bodies of law apply to the same shelf, and they are not the same rules.

A Texas reader needs both columns. A change in one does not undo the other, and a product can clear one and fail the other.

The Texas track, with dates

• 22 June 2025. Senate Bill 3 of the 89th Legislature, which would have banned the sale of virtually all hemp-derived THC products, was vetoed. The veto proclamation argued the bill "would never go into effect because of valid constitutional challenges."
• 10 September 2025. An executive order directed state agencies to bar sales of consumable hemp products to anyone under 21 and to require government-issued identification at the point of sale.
• 2 October 2025. The Department of State Health Services adopted emergency rules carrying that out, at 25 Texas Administrative Code sections 300.701 and 300.702.
• 1 May 2026. The Supreme Court of Texas decided No. 23-0887, Texas Department of State Health Services and Dr. Jennifer A. Shuford, in Her Official Capacity as Commissioner of the Texas Department of State Health Services v. Sky Marketing Corp., d/b/a Hometown Hero; Create a Cig Temple, LLC; Darrell Surif; and David Walden. The opinion states that "The legislature has charged the commissioner of the Texas Department of State Health Services with primary responsibility for overseeing the civil schedules of controlled substances," and that the statutory framework "consciously, purposefully, and expressly authorizes her" to undertake that task. It concluded: "We affirm the judgment of the court of appeals as to standing and reverse as to the ultra vires and APA claims. We render judgment reversing the trial court's order that granted the temporary injunction." Precisely: this removed the injunction that had kept the department's schedule from operating, and rejected the claims that the commissioner had acted beyond her authority. It was a decision about a temporary injunction and those claims, not a final judgment on every issue in the case.
• 31 July 2026. The department's page states that "The Texas schedule affecting delta-8 THC becomes effective July 31, 2026," and that "This scheduling action reinstates clarifications to the definitions of tetrahydrocannabinols and marihuana extract made to the 2021 Schedule of Controlled Substances." The department adds that it "intends to amend the consumable hemp product rules pursuant to the Administrative Procedure Act to include this definition" — that rulemaking is a future step and we do not describe its outcome.

Sources

Read for this page on 5 October 2026 unless noted.

• Public Law 119-37, division B, section 781, enrolled text, 139 Stat. 558-561: https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm
• Public Law 119-103, division B, section 2019, enrolled text, 140 Stat. 1003: https://www.govinfo.gov/content/pkg/PLAW-119publ103/html/PLAW-119publ103.htm
• Public Law 115-334, section 10113, the 2018 definition it replaced, 132 Stat. 4908-4909: https://www.govinfo.gov/content/pkg/PLAW-115publ334/html/PLAW-115publ334.htm
• Public Law 119-44 (the unrelated Public Health Service Act section 781): https://www.govinfo.gov/content/pkg/PLAW-119publ44/html/PLAW-119publ44.htm
• Public Law 119-74 (the industrial hemp research spending restriction): https://www.govinfo.gov/content/pkg/PLAW-119publ74/html/PLAW-119publ74.htm
• Public Law 119-117, the most recent public law published at the time of this check: https://www.govinfo.gov/content/pkg/PLAW-119publ117/html/PLAW-119publ117.htm
• U.S. House Roll Call 286, 1 September 2026, Clerk of the House: https://clerk.house.gov/evs/2026/roll286.xml
• Supreme Court of Texas, No. 23-0887, opinion delivered 1 May 2026: https://www.txcourts.gov/media/1462654/230887.pdf
• Supreme Court of Texas orders and opinions, 1 May 2026: https://www.txcourts.gov/supreme/orders-opinions/2026/may/may-1-2026/
• Texas Department of State Health Services, Consumable Hemp Program: https://www.dshs.texas.gov/consumable-hemp-program
• U.S. Food and Drug Administration, FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD) — checked for the section 781 lists; does not mention them: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
• Federal Register full-text search, Office of the Federal Register programming interface, for "capable of being naturally produced": https://www.federalregister.gov/api/v1/documents.json
• Senate Bill 3 veto proclamation and the executive order of 10 September 2025 are the Governor's own documents, at https://gov.texas.gov/news/post/governor-abbott-vetoes-senate-bill-3-89r and https://gov.texas.gov/news/post/governor-abbott-issues-executive-order-to-protect-children-from-hemp-products — both were read and quoted when this project first recorded them. That host now asks automated tools not to read it, so they were not re-read for this page, and the dates and quotations above come from our existing record of them rather than from a fresh reading.

Elsewhere on this site

• The Texas Compassionate-Use Program — Texas has one lawful route to cannabis: a prescription under the Compassionate-Use Program, for one of thirteen listed conditions. Who may prescribe, what House Bill 46 changed in 2025, and why a Yea on it scores +1 here rather than +2.
• Deadlines, photo ID and voting by mail — every date quoted from the Texas Secretary of State.
• How the score works — the whole method, including the judgments, and the bill table every score rests on.

This page describes the law and the record. Nothing here tells anyone how to vote. Every claim above carries the document it came from; if one is wrong, the correction is published.